Consensus between the American College of Cardiology and the National Lipid Association on the use of non-statin therapy for atherosclerotic cardiovascular disease prevention

J Clin Lipidol. 2016 May-Jun;10(3):458-61. doi: 10.1016/j.jacl.2016.04.004. Epub 2016 Apr 19.

Authors

Carl E Orringer¹, Pamela B Morris²

Affiliations

¹ Division of Cardiology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: carl.orringer@gmail.com.
² Medical University of South Carolina, Seinsheimer Cardiovascular Health Program, Women's Heart Care Charleston, SC, USA.

PMID: 27206930
DOI: 10.1016/j.jacl.2016.04.004

No abstract available

Publication types

Editorial

MeSH terms

American Heart Association*
Atherosclerosis
Cardiology / standards*
Cardiovascular Diseases / prevention & control
Consensus*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids
Practice Guidelines as Topic*
United States

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids